Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population (Q30939373)

11 September 2017

academic journal article

0 references

title

Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population (English)

1 reference

11 September 2017

William Kudzi

1

1 reference

11 September 2017

Alexander No Dodoo

series ordinal

2

1 reference

11 September 2017

Jeremy J Mills

series ordinal

3

1 reference

11 September 2017

Kudzi, William

0 references

Dodoo, Alexander NO

0 references

Mills, Jeremy J

0 references

Kudzi, W.

0 references

Dodoo, A.N.

0 references

Mills, J.J.

0 references

publication date

2 December 2009

1 reference

11 September 2017

2009

0 references

published in

BMC Medical Genetics

1 reference

11 September 2017

10

1 reference

11 September 2017

124

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2350-10-124

11 September 2017

0 references

http://ugspace.ug.edu.gh/handle/123456789/5629

0 references

cites work

Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Short communication: high prevalence of the cytochrome P450 2C8*2 mutation in Northern Ghana

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Clinical relevance of genetic polymorphisms in the human CYP2C9 gene

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Cytochrome P450 enzyme polymorphisms and adverse drug reactions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Allele and genotype frequency of CYP2C19 in a Tamilian population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

CYP2C9 allelic variants: ethnic distribution and functional significance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Induction of CYP2C genes in human hepatocytes in primary culture

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Major bleeding after hospitalization for deep-venous thrombosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Individual sulfonylureas and serious hypoglycemia in older people.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Drug-related hospital admissions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Biochemistry and molecular biology of the human CYP2C subfamily

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-10-124

The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-10-124

Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-10-124

CYP2C8 polymorphism frequencies among malaria patients in Zanzibar.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-10-124

Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-10-124

Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-10-124

Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-10-124

Genetic variations and haplotypes of CYP2C19 in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-10-124

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-10-124

Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-10-124

Development and evaluation of a rapid and reliable method for cytochrome P450 2C8 genotyping.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224726

Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population

25 November 2018

1 reference

12 December 2020

Common allelic variants of cytochrome P4503A4 and their prevalence in different populations

1 reference

12 December 2020

CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates

1 reference

12 December 2020

Two single-tube tetra-primer assays to detect the CYP2C19*2 and *3 alleles of S-mephenytoin hydroxylase

1 reference

12 December 2020

CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2350-10-124

1 reference

Dimensions Publication ID

11 September 2017

0 references

1 reference

11 September 2017

1 reference